To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene KIAA0020TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
299 supporting clones for gene KIAA0020 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
CD299880 testis .a 1 to 511 1 to 516   tiling clone,   516/1030
(50 %)
18 diff
(98.3 %id)
BX498270 Liver .a 101 to 615 1 to 515       515/515
(100 %)
1 diff
(99.9 %id)
NM_014878.4   .a 112 to 2328 1 to 2217   RefSeq, AAA   2217/2217
(100 %)
0 diff
(100 %id)
DA358022 subthalamic nucleus .a 113 to 686 2 to 575   capped   574/574
(100 %)
0 diff
(100 %id)
DA323795 hippocampus .a 129 to 620 2 to 493   capped   492/492
(100 %)
0 diff
(100 %id)
BU533639 mixed (pool of 40 RNAs) .a 130 to 582 1 to 453   AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 453/477
(94 %)
6 diff
(98.8 %id)
DA850169 placenta .a 130 to 666 2 to 538   capped   537/537
(100 %)
0 diff
(100 %id)
AK315531   .a 133 to 2154 1 to 2022       2022/2022
(100 %)
4 diff
(99.9 %id)
DA082816 cerebellum .a 134 to 709 2 to 577   capped   576/576
(100 %)
0 diff
(100 %id)
DA814529   .a 134 to 697 2 to 565   capped   564/564
(100 %)
1 diff
(99.9 %id)
BP364238 lung .a 134 to 716 1 to 583       583/583
(100 %)
0 diff
(100 %id)
DW424355 Liver .a 135 to 405 14 to 289       276/289
(95 %)
16 diff
(94.5 %id)
BJ989639 hepatoblastoma .a 138 to 720 1 to 583       583/583
(100 %)
0 diff
(100 %id)
BP276083 Kidney .a 138 to 710 1 to 575       575/582
(98 %)
14 diff
(97.6 %id)
DB169827 kidney, tumor tissue .a 138 to 626 2 to 490   capped   489/489
(100 %)
1 diff
(99.8 %id)
BE185499 head_neck .a 139 to 494 15 to 370       356/370
(96 %)
11 diff
(97.1 %id)
BX336375 Placenta Cot 25-normalized .a 140 to 1122 1 to 974       975/1002
(97 %)
22 diff
(97.9 %id)
BU192842 eye, retinoblastoma .a 141 to 776 1 to 644       640/829
(77 %)
13 diff
(98.5 %id)
BX111374 liver and spleen .a 142 to 561 1 to 420   AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 420/421
(99 %)
6 diff
(98.6 %id)
AV744410 cord Blood .a 142 to 554 30 to 434       405/490
(82 %)
18 diff
(96.4 %id)
BP233697 coronary artery .a 143 to 723 1 to 582       582/583
(99 %)
1 diff
(99.9 %id)
R11099.
matches multiple genes
liver and spleen .a 143 to 459 1 to 318     also hits gene sheebler 318/318
(100 %)
5 diff
(98.5 %id)
AL832239 human endometrium carcinoma cell line .a 146 to 2321 1 to 2176   available from DKFZ, AAA   2176/2177
(99 %)
3 diff
(99.9 %id)
BP233483 coronary artery .a 146 to 723 1 to 578       578/587
(98 %)
3 diff
(99.5 %id)
BF675907 Prostate .a 146 to 550 1 to 414       414/452
(91 %)
13 diff
(97.2 %id)
BF670052 brain, primitive neuroectoderm .a 146 to 823 1 to 688       687/796
(86 %)
32 diff
(96.0 %id)
TI_57240892   .a 146 to 884 25 to 771       747/884
(84 %)
18 diff
(98.0 %id)
AK225953 small intestine .a 147 to 2322 1 to 2176   AAA   2176/2176
(100 %)
2 diff
(100.0 %id)
DW431072 Liver .a 147 to 399 18 to 270       253/270
(93 %)
12 diff
(95.6 %id)
AU099467   .a 147 to 446 1 to 300       300/300
(100 %)
2 diff
(99.4 %id)
BP261979 small intestine .a 147 to 728 1 to 582       582/582
(100 %)
2 diff
(99.7 %id)
BQ278552 mixed (pool of 40 RNAs) .a 147 to 814 1 to 674       674/983
(68 %)
20 diff
(98.0 %id)
CX762122 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .a 147 to 847 1 to 698       700/868
(80 %)
10 diff
(98.9 %id)
BE439496 Trabecular meshwork .a 148 to 782 1 to 635       635/636
(99 %)
1 diff
(99.9 %id)
DA749172   .a 149 to 714 2 to 567   capped   566/566
(100 %)
2 diff
(99.7 %id)
DA885716   .a 149 to 703 2 to 556   capped   555/555
(100 %)
0 diff
(100 %id)
DB202483 trachea .a 149 to 739 2 to 592   capped   591/591
(100 %)
0 diff
(100 %id)
BP352008   .a 150 to 729 1 to 581       581/581
(100 %)
2 diff
(99.7 %id)
DA019966   .a 151 to 718 2 to 569   capped   568/568
(100 %)
1 diff
(99.9 %id)
DA488705 brain .a 151 to 723 2 to 574   capped   573/573
(100 %)
0 diff
(100 %id)
BI914616 brain .a 152 to 884 1 to 741       741/854
(86 %)
12 diff
(98.6 %id)
DA952709 Spleen .a 152 to 727 2 to 577   capped   576/576
(100 %)
0 diff
(100 %id)
CD703628 normal nasopharynx .a 154 to 605 27 to 478       452/478
(94 %)
7 diff
(98.6 %id)
BU597810 mixed (pool of 40 RNAs) .a 155 to 546 1 to 393       393/984
(39 %)
4 diff
(99.6 %id)
BU599905 mixed (pool of 40 RNAs) .a 156 to 971 1 to 815       815/816
(99 %)
12 diff
(98.6 %id)
DA960553 Spleen .a 156 to 725 2 to 571   capped   570/570
(100 %)
0 diff
(100 %id)
DN914161   .a 158 to 770 1 to 614       614/614
(100 %)
4 diff
(99.4 %id)
BU194937 melanotic melanoma, skin .a 158 to 1001 1 to 853       853/856
(99 %)
12 diff
(98.6 %id)
BX382537 Placenta Cot 25-normalized .a 159 to 1135 1 to 971       971/982
(98 %)
21 diff
(97.9 %id)
BQ278453 mixed (pool of 40 RNAs) .a 159 to 723 1 to 568       568/950
(59 %)
17 diff
(98.3 %id)
DN992183 brain, whole brain .a 159 to 895 31 to 768       738/768
(96 %)
7 diff
(99.1 %id)
BF981304 duodenal adenocarcinoma, cell line, small intestine .a 160 to 885 1 to 722       722/977
(73 %)
10 diff
(99.0 %id)
DA950730 Spleen .a 160 to 713 2 to 555   capped   554/554
(100 %)
1 diff
(99.9 %id)
DB254259 uterus .a 160 to 678 2 to 520   capped   519/519
(100 %)
0 diff
(100 %id)
BG109169 Bone, osteosarcoma, cell line .a 161 to 890 1 to 721       721/954
(75 %)
16 diff
(98.4 %id)
BG285352 adenocarcinoma, cell line, Prostate .a 161 to 884 1 to 719       719/833
(86 %)
11 diff
(98.7 %id)
CV810247 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .a 161 to 923 1 to 762       762/763
(99 %)
4 diff
(99.5 %id)
BP222223   .a 162 to 743 1 to 582       582/582
(100 %)
1 diff
(99.9 %id)
BP364867 lung .a 162 to 755 1 to 594       594/594
(100 %)
0 diff
(100 %id)
DA550535   .a 163 to 613 2 to 453   capped   452/452
(100 %)
2 diff
(99.6 %id)
CK003069 brain/CNS, Human Brain - Cerebellar Cortex .a 163 to 823 1 to 661       661/675
(97 %)
10 diff
(98.6 %id)
DA649194   .a 163 to 692 2 to 531   capped   530/530
(100 %)
1 diff
(99.9 %id)
DA915383   .a 163 to 710 2 to 549   capped   548/548
(100 %)
0 diff
(100 %id)
DA997344   .a 163 to 736 2 to 575   capped   574/574
(100 %)
0 diff
(100 %id)
BU656851 blood .a 166 to 770 5 to 609       605/609
(99 %)
6 diff
(99.1 %id)
BP236142 coronary artery .a 166 to 758 1 to 592       592/592
(100 %)
1 diff
(99.9 %id)
CV808212 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .a 166 to 895 1 to 730       730/730
(100 %)
0 diff
(100 %id)
BP282770 bone marrow .a 166 to 744 1 to 582       582/582
(100 %)
3 diff
(99.5 %id)
CR989462 T-Lymphocytes .a 166 to 637 1 to 471       471/471
(100 %)
1 diff
(99.8 %id)
DA633978 Kidney .a 167 to 748 2 to 584   capped   583/583
(100 %)
1 diff
(99.9 %id)
DB279196 uterus .a 167 to 744 2 to 579   capped   578/578
(100 %)
3 diff
(99.5 %id)
BX492244   .a 168 to 659 1 to 491       491/491
(100 %)
2 diff
(99.6 %id)
AK292169 synovial membrane tissue from rheumatoidarthritis .a 169 to 2200 1 to 2032   tiling clone,   2032/2032
(100 %)
1 diff
(100.0 %id)
DB457541 testis .a 169 to 644 1 to 477       477/477
(100 %)
2 diff
(99.6 %id)
DA766359 tongue .a 169 to 723 2 to 556   capped   555/563
(98 %)
0 diff
(100 %id)
DA209764 brain .a 170 to 736 2 to 568   capped   567/567
(100 %)
0 diff
(100 %id)
DA995323 synovial membrane tissue from rheumatioidarthritis .a 170 to 720 2 to 552   capped   551/551
(100 %)
0 diff
(100 %id)
BP284263 bone marrow .a 171 to 761 1 to 592       592/592
(100 %)
1 diff
(99.9 %id)
DB019017 esophageal, tumor tissue .a 172 to 678 2 to 508   capped   507/507
(100 %)
0 diff
(100 %id)
BG724060 testis .a 173 to 756 1 to 585       583/585
(99 %)
8 diff
(98.7 %id)
BI459280 testis .a 173 to 890 1 to 716       716/726
(98 %)
13 diff
(98.3 %id)
BP294560 Liver .a 173 to 564 1 to 391   AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 391/422
(92 %)
8 diff
(98.2 %id)
DA169836 amygdala .a 174 to 756 2 to 584   capped   583/583
(100 %)
1 diff
(99.9 %id)
CN307017 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 174 to 960 1 to 787       787/787
(100 %)
5 diff
(99.4 %id)
BM925344 brain .a 175 to 1061 18 to 908       891/1075
(82 %)
23 diff
(97.9 %id)
CT002503 T-Lymphocytes .a 175 to 863 1 to 693       693/693
(100 %)
4 diff
(99.5 %id)
BF542074 hypernephroma, Kidney .a 176 to 862 1 to 680       681/900
(75 %)
26 diff
(97.2 %id)
DA752601   .a 180 to 762 2 to 585   capped   584/584
(100 %)
1 diff
(99.9 %id)
DB450347 testis .a 181 to 643 1 to 463       463/463
(100 %)
3 diff
(99.4 %id)
DA543039   .a 181 to 734 2 to 555   capped   554/554
(100 %)
1 diff
(99.9 %id)
CX167018 human embryonic stem cells differentiated toan early endodermal cell type .a 185 to 904 1 to 720       720/720
(100 %)
0 diff
(100 %id)
BQ420543 large cell carcinoma, lung .a 186 to 1026 77 to 929       853/1190
(71 %)
14 diff
(98.9 %id)
AW239554 lung, cell line .a 188 to 735 1 to 548       548/548
(100 %)
3 diff
(99.5 %id)
DA385177 thalamus .a 190 to 770 2 to 582   capped   581/581
(100 %)
2 diff
(99.7 %id)
CN307014 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 190 to 824 1 to 634       634/638
(99 %)
3 diff
(99.6 %id)
BU194185 melanotic melanoma, skin .a 191 to 1035 1 to 848       848/848
(100 %)
5 diff
(99.5 %id)
AW239234 lung, cell line .a 194 to 810 1 to 617       617/617
(100 %)
5 diff
(99.2 %id)
AA091199   .a 197 to 357 1 to 156       156/156
(100 %)
4 diff
(97.5 %id)
CN307015 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 197 to 727 28 to 558       531/558
(95 %)
6 diff
(99.0 %id)
BX380451 Placenta Cot 25-normalized .a 197 to 1065 1 to 885       882/978
(90 %)
33 diff
(96.7 %id)
CR987226 T-Lymphocytes .a 197 to 1010 10 to 821       813/821
(99 %)
6 diff
(99.3 %id)
BF431123 Kidney .a 198 to 546 349 to 1       349/349
(100 %)
0 diff
(100 %id)
CT003263 T-Lymphocytes .a 200 to 877 19 to 695       676/695
(97 %)
8 diff
(98.9 %id)
BX482286   .a 201 to 726 1 to 526       526/526
(100 %)
3 diff
(99.5 %id)
BC016137 Uterus, leiomyosarcoma .a 208 to 2328 1 to 2121   available from MGC, AAA   2121/2121
(100 %)
3 diff
(99.9 %id)
CV023298 mixed .a 208 to 880 1 to 667       667/667
(100 %)
7 diff
(99.0 %id)
BI489585 pooled brain, lung, testis .a 208 to 995 1 to 793       793/903
(87 %)
14 diff
(98.5 %id)
TI_43961239   .a 208 to 995 45 to 837       793/947
(83 %)
21 diff
(97.8 %id)
TI_1948140364   .a 208 to 973 125 to 891       767/1301
(58 %)
20 diff
(98.5 %id)
TI_1948140365   .a 208 to 781 129 to 702       574/1330
(43 %)
21 diff
(98.5 %id)
TI_1948140696   .a 208 to 955 126 to 871       746/1310
(56 %)
29 diff
(97.8 %id)
TI_1948140697   .a 208 to 817 133 to 742       610/1430
(42 %)
23 diff
(98.4 %id)
TI_1948141023   .a 208 to 920 124 to 839       716/1399
(51 %)
21 diff
(98.5 %id)
TI_1948141024   .a 208 to 890 129 to 812       684/1428
(47 %)
20 diff
(98.6 %id)
TI_1948141360   .a 208 to 884 125 to 806       682/1403
(48 %)
13 diff
(99.1 %id)
TI_1948141361   .a 208 to 1014 128 to 938       811/1379
(58 %)
27 diff
(98.1 %id)
D13645   .a 210 to 2321 1 to 2112   available from KIAA,   2112/2112
(100 %)
1 diff
(100.0 %id)
CB162869 Liver .a 211 to 782 1 to 572       572/572
(100 %)
0 diff
(100 %id)
DA613747   .a 214 to 797 2 to 587   capped   586/586
(100 %)
3 diff
(99.5 %id)
BE886817 leiomyosarcoma, uterus .a 216 to 1003 1 to 786       786/889
(88 %)
17 diff
(98.1 %id)
TI_59393856   .a 220 to 655 90 to 525       436/722
(60 %)
5 diff
(99.4 %id)
BM015604 breast, mammary adenocarcinoma, cell line .a 221 to 655 1 to 435       435/455
(95 %)
5 diff
(99.0 %id)
CV809598 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .a 222 to 1058 1 to 844       844/886
(95 %)
21 diff
(97.7 %id)
W76608 heart .a 225 to 600 1 to 378       378/378
(100 %)
3 diff
(99.3 %id)
BF063334 colon, colon tumor, RER+ .a 247 to 545 299 to 1       299/299
(100 %)
0 diff
(100 %id)
AI861878 Kidney .a 254 to 546 293 to 1       293/293
(100 %)
0 diff
(100 %id)
BG949845 breast_normal .a 255 to 561 1 to 307       307/307
(100 %)
0 diff
(100 %id)
CN307019 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 262 to 817 1 to 556       556/556
(100 %)
0 diff
(100 %id)
R11071.
matches multiple genes
liver and spleen .a 265 to 535 271 to 1     also hits gene shyflawby 271/271
(100 %)
3 diff
(98.9 %id)
BX421001 brain, fetal brain .a 290 to 956 135 to 794       660/803
(82 %)
18 diff
(97.8 %id)
BX349677 Placenta Cot 25-normalized .a 290 to 1099 1 to 830       629/830
(75 %)
17 diff
(98.0 %id)
BP341803 stomach mucosa .a 325 to 897 1 to 573       573/573
(100 %)
0 diff
(100 %id)
BE815659 breast_normal .a 360 to 559 1 to 199       199/201
(99 %)
2 diff
(99.1 %id)
AA173490   .a 450 to 799 12 to 363       352/363
(96 %)
9 diff
(97.6 %id)
BP354136   .a 468 to 1049 1 to 583       583/583
(100 %)
1 diff
(99.9 %id)
CN307013 embryonic stem cells, DMSO-treated H9 cellline .a 482 to 992 1 to 511       511/512
(99 %)
1 diff
(99.9 %id)
T29000 blood, white blood cells .a 482 to 785 1 to 306       306/306
(100 %)
2 diff
(99.4 %id)
AW966687   .a 483 to 1026 1 to 543       543/543
(100 %)
25 diff
(95.4 %id)
CN307012 embryonic stem cells, DMSO-treated H9 cellline .a 542 to 1322 1 to 782       782/782
(100 %)
2 diff
(99.8 %id)
BX429419 brain, fetal brain .a 542 to 1342 1 to 800       800/800
(100 %)
12 diff
(98.5 %id)
AF490254   .a 628 to 2154 1 to 1527       1527/1527
(100 %)
1 diff
(100.0 %id)
CR456957   .a 628 to 2153 1 to 1526       1526/1527
(99 %)
4 diff
(99.8 %id)
BX367893 Placenta Cot 25-normalized .a 656 to 1527 1 to 872       872/876
(99 %)
7 diff
(99.3 %id)
BU178015 melanotic melanoma, skin .a 686 to 1469 12 to 804       791/901
(87 %)
23 diff
(97.5 %id)
BX325908 Placenta Cot 25-normalized .a 727 to 1167 1 to 445       445/528
(84 %)
36 diff
(93.2 %id)
AA307160 colon .a 761 to 1253 1 to 493       493/493
(100 %)
2 diff
(99.6 %id)
AW949321   .a 762 to 1290 1 to 529       529/529
(100 %)
0 diff
(100 %id)
BM043114 carcinoma, cell line, Prostate .a 817 to 1625 2 to 809       808/811
(99 %)
27 diff
(96.7 %id)
BQ108674 carcinoma, cell line, Prostate .a 817 to 1576 1 to 762       762/762
(100 %)
7 diff
(99.1 %id)
BQ919996 carcinoma, cell line, Prostate .a 818 to 1566 1 to 756       756/958
(78 %)
20 diff
(98.0 %id)
BX326362 Placenta Cot 25-normalized .a 836 to 1721 1 to 887       887/896
(98 %)
27 diff
(97.0 %id)
BX370163 Placenta Cot 25-normalized .a 836 to 1748 1 to 914       914/914
(100 %)
21 diff
(97.8 %id)
BM478947 duodenal adenocarcinoma, cell line, small intestine .a 836 to 1340 31 to 536       506/1261
(40 %)
15 diff
(98.9 %id)
BX388861 Placenta Cot 25-normalized .a 839 to 1735 19 to 906       890/906
(98 %)
22 diff
(97.6 %id)
AU123270   .a 888 to 1625 2 to 740   capped   739/828
(89 %)
12 diff
(98.6 %id)
AU123334   .a 891 to 1727 2 to 839   capped   838/838
(100 %)
21 diff
(97.5 %id)
AA478933 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .a 906 to 1159 1 to 254       254/256
(99 %)
9 diff
(96.5 %id)
AY047588   .a 910 to 1256 1 to 347       347/347
(100 %)
2 diff
(99.5 %id)
AY047589   .a 910 to 1256 1 to 347       347/347
(100 %)
1 diff
(99.8 %id)
AY047590   .a 910 to 1256 1 to 347       347/347
(100 %)
0 diff
(100 %id)
BX388854 Placenta Cot 25-normalized .a 942 to 1870 9 to 936       928/936
(99 %)
5 diff
(99.5 %id)
BQ643536 hepatocellular carcinoma, cell line, Liver .a 943 to 1837 10 to 909       900/973
(92 %)
16 diff
(98.4 %id)
BQ896705 hepatocellular carcinoma, cell line, Liver .a 943 to 1551 56 to 668       613/1229
(49 %)
15 diff
(98.8 %id)
BX450532 brain, fetal brain .a 948 to 1811 859 to 1       857/904
(94 %)
20 diff
(97.8 %id)
BQ653949 hepatocellular carcinoma, cell line, Liver .a 949 to 1783 1 to 844       844/960
(87 %)
19 diff
(98.1 %id)
BQ647139 hepatocellular carcinoma, cell line, Liver .a 954 to 1930 1 to 978       976/978
(99 %)
21 diff
(97.9 %id)
AW363101 colon .a 957 to 1486 13 to 539       527/543
(97 %)
26 diff
(95.3 %id)
BQ647059 hepatocellular carcinoma, cell line, Liver .a 959 to 1767 18 to 834       817/954
(85 %)
21 diff
(97.8 %id)
AW363100 colon .a 973 to 1290 1 to 318       318/318
(100 %)
5 diff
(98.5 %id)
CD105617 brain, Pituitary .a 978 to 1797 32 to 858       827/931
(88 %)
23 diff
(97.6 %id)
BM725854 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .a 1020 to 1476 1 to 458       458/458
(100 %)
9 diff
(98.1 %id)
BE827298 lung_tumor .a 1044 to 1152 133 to 25       109/133
(81 %)
0 diff
(100 %id)
BM473628 duodenal adenocarcinoma, cell line, small intestine .a 1071 to 2016 13 to 964       950/1082
(87 %)
25 diff
(97.7 %id)
CB119096 Liver .a 1091 to 1542 1 to 452       452/452
(100 %)
0 diff
(100 %id)
BE741054 adenocarcinoma cell line, ovary .a 1096 to 1867 1 to 771       771/775
(99 %)
10 diff
(98.8 %id)
BM476257 duodenal adenocarcinoma, cell line, small intestine .a 1096 to 2018 1 to 931       929/1093
(84 %)
23 diff
(97.9 %id)
BM794780 Ascites, stomach .a 1137 to 1757 1 to 622       622/622
(100 %)
7 diff
(98.9 %id)
BX326467 Placenta Cot 25-normalized .a 1166 to 1582 417 to 1       417/503
(82 %)
4 diff
(99.3 %id)
BF357711 leiomios .a 1188 to 1579 24 to 415       392/419
(93 %)
7 diff
(98.4 %id)
CN307018 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 1202 to 1877 1 to 676       676/676
(100 %)
1 diff
(99.9 %id)
BP395884 pancreatic islet .a 1221 to 1722 502 to 1       502/502
(100 %)
0 diff
(100 %id)
CX166288 human embryonic stem cells differentiated toan early endodermal cell type .a 1239 to 2072 1 to 834       834/834
(100 %)
1 diff
(99.9 %id)
FN077534 breast carcinoma .a 1248 to 1300 54 to 1     Submitted on the opposite strand 54/55
(98 %)
1 diff
(98.2 %id)
BU786437 Pancreas, Purified pancreatic islet .a 1308 to 1812 1 to 505   fully sequenced,   505/505
(100 %)
9 diff
(98.3 %id)
CN307016 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 1332 to 1967 1 to 638       638/638
(100 %)
3 diff
(99.6 %id)
BX336374 Placenta Cot 25-normalized .a 1339 to 2308 968 to 1       968/1051
(92 %)
7 diff
(99.4 %id)
FN151835 breast carcinoma .a 1348 to 1453 1 to 111       108/111
(97 %)
7 diff
(93.7 %id)
EH325140   .a 1379 to 1461 1 to 82       82/82
(100 %)
1 diff
(98.8 %id)
TI_1948140699   .a 1395 to 2153 900 to 138       763/1351
(56 %)
16 diff
(98.9 %id)
TI_1948140367   .a 1397 to 2153 894 to 139       756/1269
(59 %)
7 diff
(99.5 %id)
BI016414 lung_tumor .a 1398 to 1798 401 to 1       401/401
(100 %)
1 diff
(99.8 %id)
DN912670   .a 1401 to 1741 30 to 370       341/370
(92 %)
7 diff
(98.2 %id)
AI744355 ovary, tumor, 5 pooled (see description) .a 1403 to 1905 504 to 1       504/530
(95 %)
4 diff
(99.3 %id)
AA452352   .a 1404 to 1909 1 to 506       506/547
(92 %)
4 diff
(99.3 %id)
BX392988 Placenta Cot 25-normalized .a 1465 to 2310 846 to 1       846/846
(100 %)
10 diff
(98.9 %id)
TI_1948141025   .a 1465 to 2151 821 to 126       696/1423
(48 %)
23 diff
(98.4 %id)
TI_1948141026   .a 1465 to 2151 827 to 141       687/1328
(51 %)
9 diff
(99.4 %id)
TI_149309894   .a 1466 to 2328 963 to 102   AAA   862/967
(89 %)
13 diff
(98.7 %id)
AI620087 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .a 1468 to 1903 434 to 1       434/434
(100 %)
9 diff
(98.0 %id)
TI_1948141363   .a 1468 to 2153 831 to 142       690/1396
(49 %)
13 diff
(99.1 %id)
TI_149309628   .a 1468 to 2322 927 to 86   AAA   842/943
(89 %)
24 diff
(97.5 %id)
TI_154128903   .a 1468 to 2321 939 to 90   AAA   850/996
(85 %)
13 diff
(98.7 %id)
BX425221 neuroblastoma .a 1477 to 2322 1 to 846       846/846
(100 %)
2 diff
(99.8 %id)
BX428660 neuroblastoma .a 1477 to 1676 1 to 200       200/210
(95 %)
1 diff
(99.6 %id)
CR605925 neuroblastoma .a 1477 to 2322 1 to 846       846/846
(100 %)
0 diff
(100 %id)
BX421000 brain, fetal brain .a 1477 to 2288 813 to 1       813/813
(100 %)
4 diff
(99.6 %id)
TI_154125034   .a 1477 to 2321 890 to 70   AAA   821/941
(87 %)
14 diff
(98.6 %id)
BX330429 Placenta Cot 25-normalized .a 1479 to 2319 840 to 1       840/843
(99 %)
10 diff
(98.9 %id)
AW668620 gastric epithelial cell GES-1, stomach .a 1490 to 1779 1 to 290   AAA   290/301
(96 %)
4 diff
(98.7 %id)
CR748207 pooled germ cell tumors .a 1498 to 1978 1 to 481       481/481
(100 %)
1 diff
(99.8 %id)
TI_149315477   .a 1501 to 2322 900 to 90   AAA   811/981
(82 %)
17 diff
(98.3 %id)
TI_154035318   .a 1507 to 2322 897 to 84   AAA   814/954
(85 %)
11 diff
(98.9 %id)
BX349676 Placenta Cot 25-normalized .a 1532 to 2322 789 to 1       789/789
(100 %)
14 diff
(98.3 %id)
BM464909 lymph, lymphoma, cell line .a 1536 to 2322 31 to 817   AAA   787/818
(96 %)
15 diff
(98.2 %id)
BF981804 duodenal adenocarcinoma, cell line, small intestine .a 1537 to 2221 1 to 680       680/935
(72 %)
12 diff
(98.8 %id)
CA430160 Cell Line, Chondrosarcoma .a 1547 to 2321 791 to 19   AAA   773/773
(100 %)
3 diff
(99.7 %id)
BF908642 uterus_tumor .a 1556 to 1798 20 to 262       243/262
(92 %)
6 diff
(97.8 %id)
CA417805 Chondrosarcoma Cell line .a 1561 to 2321 779 to 19   AAA   761/761
(100 %)
3 diff
(99.7 %id)
BU620705 cell lines, Chondrosarcoma .a 1561 to 2328 785 to 19   AAA   767/767
(100 %)
2 diff
(99.8 %id)
BQ775523 Bone, Human Chondrosarcoma Cell Line .a 1563 to 2322 775 to 19   AAA   757/757
(100 %)
5 diff
(99.4 %id)
BU688008 lung .a 1565 to 2322 773 to 19   AAA   755/755
(100 %)
5 diff
(99.4 %id)
TI_1948141362   .a 1573 to 2153 707 to 125       583/1425
(40 %)
32 diff
(97.8 %id)
BU631170 cell lines, Chondrosarcoma .a 1579 to 2335 767 to 12   AAA   756/756
(100 %)
5 diff
(99.4 %id)
BU688253 lung .a 1606 to 2328 741 to 19   AAA   723/723
(100 %)
1 diff
(99.9 %id)
AI953907 brain, three pooled meningiomas .a 1616 to 2322 714 to 4       711/718
(99 %)
10 diff
(98.7 %id)
AI743549 pooled .a 1618 to 2333 718 to 2       717/718
(99 %)
5 diff
(99.4 %id)
BQ045357 lung, Primary Lung Cystic Fibrosis EpithelialCells .a 1618 to 2322 723 to 19   AAA   705/705
(100 %)
1 diff
(99.9 %id)
BQ021653 lung, Metastatic Chondrosarcoma .a 1622 to 2321 717 to 19   AAA   699/700
(99 %)
4 diff
(99.5 %id)
FN068995 breast carcinoma .a 1625 to 1703 80 to 1     Submitted on the opposite strand 80/81
(98 %)
1 diff
(98.8 %id)
EC512002 Prostate .a 1630 to 1727 1 to 98       98/98
(100 %)
1 diff
(99.0 %id)
BE465880 Kidney .a 1651 to 2330 680 to 1       680/680
(100 %)
3 diff
(99.6 %id)
BM789425 Ascites, stomach .a 1654 to 2123 1 to 470       470/470
(100 %)
0 diff
(100 %id)
CA442401 Fibrosarcoma .a 1668 to 2321 672 to 19   AAA   654/654
(100 %)
0 diff
(100 %id)
BM853123 Ascites, stomach .a 1681 to 2019 1 to 339       339/339
(100 %)
2 diff
(99.5 %id)
CA443912 Fibrosarcoma .a 1684 to 2322 657 to 19   AAA   639/639
(100 %)
1 diff
(99.9 %id)
BF665244 brain, primitive neuroectoderm .a 1689 to 2300 1 to 610       610/830
(73 %)
17 diff
(98.0 %id)
TI_149289158   .a 1695 to 2337 736 to 96   AAA   641/641
(100 %)
5 diff
(99.3 %id)
CA416004 Chondrosarcoma Cell line .a 1699 to 2321 640 to 19   AAA   622/622
(100 %)
2 diff
(99.7 %id)
BI490715 pooled brain, lung, testis .a 1717 to 2247 546 to 5       538/558
(96 %)
17 diff
(97.0 %id)
TI_43961241   .a 1717 to 2247 546 to 5       538/558
(96 %)
17 diff
(97.0 %id)
BU622994 cell lines, Chondrosarcoma .a 1752 to 2322 589 to 19   AAA   571/571
(100 %)
3 diff
(99.5 %id)
BM970751 lung .a 1761 to 2337 595 to 19   tiling clone, AAA   577/577
(100 %)
1 diff
(99.9 %id)
BJ989640 hepatoblastoma .a 1763 to 2302 540 to 1       540/540
(100 %)
0 diff
(100 %id)
BX453983 neuroblastoma .a 1765 to 2303 551 to 10       542/693
(78 %)
15 diff
(97.9 %id)
AW664128 2 pooled high-grade transitional celltumors, genitourinary tract .a 1768 to 2321 554 to 1       554/554
(100 %)
1 diff
(99.9 %id)
AI457576 pooled .a 1773 to 2333 564 to 2       563/565
(99 %)
10 diff
(98.3 %id)
BU784712 Pancreas, Purified pancreatic islet .a 1783 to 2328 561 to 16   fully sequenced, AAA   546/546
(100 %)
12 diff
(97.9 %id)
AW444710   .a 1805 to 2328 541 to 18   AAA   524/524
(100 %)
1 diff
(99.9 %id)
AW878564 ovary .a 1813 to 2062 1 to 250       250/291
(85 %)
3 diff
(99.0 %id)
BF908643 uterus_tumor .a 1813 to 1955 1 to 143       143/143
(100 %)
2 diff
(98.7 %id)
BI016413 lung_tumor .a 1813 to 1993 182 to 3       180/182
(98 %)
7 diff
(96.2 %id)
EC487254 Prostate .a 1814 to 1901 89 to 3       87/89
(97 %)
0 diff
(100 %id)
BM808387 ovary (pool of 3) .a 1826 to 2336 71 to 586       516/1367
(37 %)
25 diff
(98.2 %id)
AI284062 colon, moderately-differentiated adenocarcinoma .a 1841 to 2321 486 to 6       481/505
(95 %)
5 diff
(99.1 %id)
AW169608 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .a 1841 to 2328 487 to 1       487/521
(93 %)
6 diff
(98.9 %id)
DB523017 testis .a 1864 to 2320 1 to 457     Submitted on the opposite strand 457/464
(98 %)
1 diff
(99.8 %id)
AA809771 germinal center B cell .a 1864 to 2321 473 to 17   AAA   457/460
(99 %)
6 diff
(98.7 %id)
AI865348 lymph node, lymphoma, follicular mixed small and largecell .a 1891 to 2334 446 to 2       445/449
(99 %)
2 diff
(99.6 %id)
BF508171   .a 1894 to 2322 446 to 18   AAA   429/429
(100 %)
4 diff
(99.1 %id)
BE549088 cervical carcinoma cell line, cervix .a 1897 to 2325 1 to 429       429/429
(100 %)
2 diff
(99.6 %id)
AA618311 thyroid .a 1904 to 2285 8 to 389       382/389
(98 %)
7 diff
(98.3 %id)
AA452129   .a 1929 to 2334 407 to 3       405/536
(75 %)
1 diff
(99.9 %id)
AA456277 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .a 1929 to 2304 9 to 385   fully sequenced,   377/385
(97 %)
6 diff
(98.5 %id)
AI186424 placenta .a 1929 to 2094 166 to 1       166/168
(98 %)
1 diff
(99.5 %id)
BX428659 neuroblastoma .a 1931 to 2302 375 to 5       371/375
(98 %)
5 diff
(98.7 %id)
AA907553 pooled .a 1931 to 2327 398 to 1       398/440
(90 %)
3 diff
(99.4 %id)
AA173381   .a 1943 to 2321 382 to 2       381/383
(99 %)
2 diff
(99.5 %id)
BI496845 cochlea, ear .a 1953 to 2328 8 to 383   fully sequenced, AAA   376/383
(98 %)
0 diff
(100 %id)
AA534032 invasive prostate tumor, Prostate .a 1956 to 2321 1 to 366   AAA   366/366
(100 %)
5 diff
(98.7 %id)
FN134816 breast carcinoma .a 1960 to 2040 81 to 1     Submitted on the opposite strand 81/84
(96 %)
5 diff
(94.1 %id)
BU537424 mixed (pool of 40 RNAs) .a 1963 to 2321 1 to 359       359/394
(91 %)
2 diff
(99.5 %id)
AI369959   .a 1969 to 2333 367 to 4       364/367
(99 %)
1 diff
(99.8 %id)
AA454662 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .a 1991 to 2321 331 to 1   fully sequenced,   331/331
(100 %)
0 diff
(100 %id)
AW000933 Kidney .a 2008 to 2322 316 to 1       316/316
(100 %)
2 diff
(99.4 %id)
AW298707   .a 2037 to 2321 302 to 18   AAA   285/285
(100 %)
4 diff
(98.6 %id)
EC563745 Prostate .a 2141 to 2250 1 to 108       108/108
(100 %)
2 diff
(98.2 %id)
BI496844 cochlea, ear .a 2253 to 2325 93 to 20   fully sequenced, AAA   74/74
(100 %)
5 diff
(93.3 %id)
CR607424 fetal brain .b 1 to 2126 3 to 2128 exact tiling clone,   2128/2128
(100 %)
0 diff
(100 %id)
AU135262 placenta .c 1 to 662 2 to 664   tiling clone, capped   663/708
(93 %)
2 diff
(99.8 %id)
AL832245 human endometrium carcinoma cell line .c 2 to 2171 1 to 2167 R155E V156* tiling clone, available from DKFZ, AAA   2167/2167
(100 %)
6 diff
(99.8 %id)
AU155934 placenta .c 1691 to 2178 488 to 1       488/572
(85 %)
4 diff
(99.4 %id)
BM917085 blood, natural killer cells, cell line .d 1 to 930 1 to 934 K258Q T266X E272* tiling clone,   1006/1092
(92 %)
36 diff
(96.8 %id)
BX382536 Placenta Cot 25-normalized .e 1 to 951 964 to -1 A13X I19N I20H E21* tiling clone,   962/1047
(91 %)
35 diff
(96.7 %id)
AI936509 pooled .f 1 to 458 466 to 9 exact tiling clone,   458/466
(98 %)
0 diff
(100 %id)
BI046550 prostate_normal .g 1 to 351 354 to 5 M28V E55D H56V R57A I58S tiling clone,   350/354
(98 %)
1 diff
(99.8 %id)
FN054236 breast carcinoma .g 88 to 198 111 to 1     Submitted on the opposite strand 111/111
(100 %)
0 diff
(100 %id)
N90372 liver and spleen .h -151 to 152 153 to 463       463/467
(99 %)
17 diff
(96.4 %id)
CN430661 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .h -142 to 566 1 to 708       708/717
(98 %)
4 diff
(99.5 %id)
DN914160   .h -82 to 403 486 to 1       486/486
(100 %)
3 diff
(99.4 %id)
AW294497   .h -22 to 404 444 to 18   AAA   427/437
(97 %)
0 diff
(100 %id)
BF980429 duodenal adenocarcinoma, cell line, small intestine .h -9 to 569 42 to 622   tiling clone, AAA   581/622
(93 %)
6 diff
(99.1 %id)
BX504890   .h 1 to 1628 3 to 661       661/661
(100 %)
4 diff
(99.4 %id)
N45516 multiple sclerosis lesions .h 1 to 368 1 to 371   tiling clone,   371/436
(85 %)
5 diff
(98.9 %id)
AU138465 placenta .h 110 to 837 2 to 729   tiling clone, capped   728/774
(94 %)
17 diff
(97.9 %id)
AA705027 liver and spleen .h 119 to 569 448 to 1       448/448
(100 %)
4 diff
(99.2 %id)
N68560.
matches multiple genes
liver and spleen .h 185 to 570 387 to 1   tiling clone, also hits gene HIPK1 387/387
(100 %)
7 diff
(98.2 %id)
DW446472 Liver .h 255 to 403 17 to 165   AAA   149/166
(89 %)
1 diff
(99.4 %id)
AA577507 colon, colon tumor .h 303 to 536 234 to 1       234/234
(100 %)
0 diff
(100 %id)
N47614 multiple sclerosis lesions .h 369 to 574 206 to 1   tiling clone,   206/206
(100 %)
1 diff
(99.6 %id)
DB378242 placenta .h 2221 to 2700 479 to 1   tiling clone,   479/479
(100 %)
11 diff
(97.8 %id)
BM463352 embryonal carcinoma, cell line, testis .i-u 1 to 1023 28 to 1062 S2Y L3E T4F S5* tiling clone,   1035/1064
(97 %)
38 diff
(96.5 %id)
BU588004 mixed (pool of 40 RNAs) .j-u 1 to 462 3 to 464 exact tiling clone,   464/466
(99 %)
7 diff
(98.5 %id)
DA421376 cervix .j-u 3 to 457 2 to 456 exact tiling clone, capped   455/455
(100 %)
4 diff
(99.2 %id)
AA437113   .k-u 1 to 369 369 to 1 C45S tiling clone,   369/369
(100 %)
2 diff
(99.5 %id)
GD158352   .l 1 to 173 175 to 4 L2F L3F S6L V7F F8S ... tiling clone, Submitted on the opposite strand 172/175
(98 %)
3 diff
(98.3 %id)
BC020598 Liver Gene KIAA0020, variant not shown       available from MGC, AAA This clone was ignored    
BG567472 Liver Gene KIAA0020, variant not shown       available from MGC, This clone was ignored    
CD642973 Embryonic Stem cells Gene KIAA0020, variant not shown         This clone was ignored    
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f, .g, .h, .i-u, .j-u, .k-u, .l Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes CI